Skip to content

MDT

Medtronic plc

Income statement

Income statement
Line, in USDLast 12 monthsFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013
Revenue37.5B36.4B33.5B32.4B31.2B31.7B30.1B28.9B30.6B30.0B29.7B28.8B20.3B17.0B16.6B
Cost of revenue
13.1B12.7B11.6B11.2B10.7B10.1B10.5B9.4B9.2B9.1B9.3B9.1B6.3B4.3B4.1B
Gross profit24.4B23.6B21.9B21.1B20.5B21.5B19.6B19.5B21.4B20.9B20.4B19.7B14.0B12.7B12.5B
2.92B2.87B2.73B2.74B2.70B2.75B2.49B2.33B2.33B2.26B2.19B2.22B1.64B1.48B1.56B
12.2B11.8B10.8B10.7B10.4B10.3B10.1B10.1B10.4B10.2B10.0B9.5B6.9B5.8B5.7B
Other operating expenses
2.52B2.52B2.37B2.53B1.91B2.75B2.51B2.26B2.39B1.76B2.83B2.64B1.64B1.54B0.81B
Operating income6.79B6.47B5.96B5.14B5.49B5.75B4.48B4.79B6.27B6.64B5.38B5.36B3.77B3.81B4.40B
Non-operating income
−0.18B−0.33B−0.33B−0.31B−0.12B−0.24B−0.59B−0.74B−1.07B−0.97B−0.78B−1.03B−0.28B−0.11B−0.15B
Pretax income6.60B6.14B5.63B4.84B5.36B5.52B3.90B4.06B5.20B5.68B4.60B4.34B3.49B3.71B4.25B
Taxes
1.37B1.34B0.97B1.16B1.61B0.48B0.29B−0.73B0.57B2.57B0.57B0.80B0.81B0.64B0.78B
Net income5.23B4.80B4.66B3.68B3.76B5.04B3.61B4.79B4.63B3.10B4.03B3.54B2.68B3.07B3.47B
Diluted EPS4.073.733.612.762.823.732.663.543.412.272.892.482.413.023.37
Diluted shares—1.29B1.29B1.33B1.33B1.35B1.35B1.35B1.36B1.37B1.39B1.43B1.11B1.01B1.03B
Revenue growth—+8.4%+3.6%+3.6%−1.4%+5.2%+4.2%−5.4%+2.0%+0.8%+3.0%+42.3%+19.1%+2.5%—
Gross margin65.0%65.0%65.3%65.3%65.7%68.0%65.2%67.4%70.0%69.8%68.7%68.3%68.9%74.5%75.1%
Operating margin18.1%17.8%17.8%15.9%17.6%18.2%14.9%16.6%20.5%22.2%18.1%18.6%18.6%22.4%26.5%
Net margin13.9%13.2%13.9%11.4%12.0%15.9%12.0%16.6%15.2%10.4%13.6%12.3%13.2%18.0%20.9%